Literature DB >> 26744966

Off-the-shelf CAR-T therapy induces remission in child with ALL.

Mark Ratner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26744966     DOI: 10.1038/nbt0116-12

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  CAR-T field booms as next-generation platforms attract big players.

Authors:  Chris Morrison
Journal:  Nat Biotechnol       Date:  2015-06       Impact factor: 54.908

  1 in total
  5 in total

1.  CAR-T cells forge ahead, Novartis reorganizes.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

2.  Allogene and Celularity move CAR-T therapy off the shelf.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2018-05-09       Impact factor: 54.908

Review 3.  CAR T-Cell Therapy: Progress and Prospects.

Authors:  Olivia Wilkins; Allison M Keeler; Terence R Flotte
Journal:  Hum Gene Ther Methods       Date:  2017-04       Impact factor: 2.396

Review 4.  Gene Therapy 2017: Progress and Future Directions.

Authors:  A M Keeler; M K ElMallah; T R Flotte
Journal:  Clin Transl Sci       Date:  2017-05-23       Impact factor: 4.689

Review 5.  Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment.

Authors:  Zhenguang Wang; Yelei Guo; Weidong Han
Journal:  Protein Cell       Date:  2017-05-02       Impact factor: 14.870

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.